Researchers report initial feasibility of identifying patients who are exceptional responders to cancer therapy

A pilot study evaluating identification of cancer patients who respond to treatment that is ineffective in at least 90 percent of patients found that it was indeed able to confirm a majority of proposed patients as exceptional responders based on clinical data submitted for consideration. Being able to identify which patients are actual exceptional responders is an important step in determining why these patients respond so uniquely. …read more

Source:: Cancer